Review



kcas bio analytical  (KCAS Bioanalytical and Biomarker Services)


Bioz Verified Symbol KCAS Bioanalytical and Biomarker Services is a verified supplier
Bioz Manufacturer Symbol KCAS Bioanalytical and Biomarker Services manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    KCAS Bioanalytical and Biomarker Services kcas bio analytical
    Kcas Bio Analytical, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 99/100, based on 612 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multiplex+microarray+detection+platform/Large+Molecule+Bioanalysis/pm40684393-96-17-17
    Average 99 stars, based on 612 article reviews
    kcas bio analytical - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    Biomarker Discovery:

    Article Title: In Vivo Multimodal Self-Immolative Prodrug Nanomicelle-Hydrogel Modulate Key Intratumoral and Metastatic Genomic Signaling Pathways in Pancreatic Cancer
    Article Snippet: nomedicine has demonstrated numerically higher efficacy and safety compared to standard systemic free drug CT by overcoming some of these challenges, namely: (i) avoiding side and offtarget effects by active biomarker targeting or EPR at the site of interest; (ii) enhancing intracellular uptake in cancer and metastatic cells; (iii) improving controlled payload pharmacokinetics and pharmacodynamics;

    Drug discovery:

    Article Title: In Vivo Multimodal Self-Immolative Prodrug Nanomicelle-Hydrogel Modulate Key Intratumoral and Metastatic Genomic Signaling Pathways in Pancreatic Cancer
    Article Snippet: nomedicine has demonstrated numerically higher efficacy and safety compared to standard systemic free drug CT by overcoming some of these challenges, namely: (i) avoiding side and offtarget effects by active biomarker targeting or EPR at the site of interest; (ii) enhancing intracellular uptake in cancer and metastatic cells; (iii) improving controlled payload pharmacokinetics and pharmacodynamics;

    DNA Synthesis:

    Article Title: In Vivo Multimodal Self-Immolative Prodrug Nanomicelle-Hydrogel Modulate Key Intratumoral and Metastatic Genomic Signaling Pathways in Pancreatic Cancer
    Article Snippet: nomedicine has demonstrated numerically higher efficacy and safety compared to standard systemic free drug CT by overcoming some of these challenges, namely: (i) avoiding side and offtarget effects by active biomarker targeting or EPR at the site of interest; (ii) enhancing intracellular uptake in cancer and metastatic cells; (iii) improving controlled payload pharmacokinetics and pharmacodynamics;

    Imaging:

    Article Title: In Vivo Multimodal Self-Immolative Prodrug Nanomicelle-Hydrogel Modulate Key Intratumoral and Metastatic Genomic Signaling Pathways in Pancreatic Cancer
    Article Snippet: nomedicine has demonstrated numerically higher efficacy and safety compared to standard systemic free drug CT by overcoming some of these challenges, namely: (i) avoiding side and offtarget effects by active biomarker targeting or EPR at the site of interest; (ii) enhancing intracellular uptake in cancer and metastatic cells; (iii) improving controlled payload pharmacokinetics and pharmacodynamics;

    Clinical Proteomics:

    Article Title: In Vivo Multimodal Self-Immolative Prodrug Nanomicelle-Hydrogel Modulate Key Intratumoral and Metastatic Genomic Signaling Pathways in Pancreatic Cancer
    Article Snippet: nomedicine has demonstrated numerically higher efficacy and safety compared to standard systemic free drug CT by overcoming some of these challenges, namely: (i) avoiding side and offtarget effects by active biomarker targeting or EPR at the site of interest; (ii) enhancing intracellular uptake in cancer and metastatic cells; (iii) improving controlled payload pharmacokinetics and pharmacodynamics;

    Magnetic Resonance Imaging:

    Article Title: In Vivo Multimodal Self-Immolative Prodrug Nanomicelle-Hydrogel Modulate Key Intratumoral and Metastatic Genomic Signaling Pathways in Pancreatic Cancer
    Article Snippet: nomedicine has demonstrated numerically higher efficacy and safety compared to standard systemic free drug CT by overcoming some of these challenges, namely: (i) avoiding side and offtarget effects by active biomarker targeting or EPR at the site of interest; (ii) enhancing intracellular uptake in cancer and metastatic cells; (iii) improving controlled payload pharmacokinetics and pharmacodynamics;

    Diagnostic Assay:

    Article Title: In Vivo Multimodal Self-Immolative Prodrug Nanomicelle-Hydrogel Modulate Key Intratumoral and Metastatic Genomic Signaling Pathways in Pancreatic Cancer
    Article Snippet: nomedicine has demonstrated numerically higher efficacy and safety compared to standard systemic free drug CT by overcoming some of these challenges, namely: (i) avoiding side and offtarget effects by active biomarker targeting or EPR at the site of interest; (ii) enhancing intracellular uptake in cancer and metastatic cells; (iii) improving controlled payload pharmacokinetics and pharmacodynamics;

    Virus:

    Article Title: In Vivo Multimodal Self-Immolative Prodrug Nanomicelle-Hydrogel Modulate Key Intratumoral and Metastatic Genomic Signaling Pathways in Pancreatic Cancer
    Article Snippet: nomedicine has demonstrated numerically higher efficacy and safety compared to standard systemic free drug CT by overcoming some of these challenges, namely: (i) avoiding side and offtarget effects by active biomarker targeting or EPR at the site of interest; (ii) enhancing intracellular uptake in cancer and metastatic cells; (iii) improving controlled payload pharmacokinetics and pharmacodynamics;

    Neutralization:

    Article Title: In Vivo Multimodal Self-Immolative Prodrug Nanomicelle-Hydrogel Modulate Key Intratumoral and Metastatic Genomic Signaling Pathways in Pancreatic Cancer
    Article Snippet: nomedicine has demonstrated numerically higher efficacy and safety compared to standard systemic free drug CT by overcoming some of these challenges, namely: (i) avoiding side and offtarget effects by active biomarker targeting or EPR at the site of interest; (ii) enhancing intracellular uptake in cancer and metastatic cells; (iii) improving controlled payload pharmacokinetics and pharmacodynamics;

    Incubation:

    Article Title: In Vivo Multimodal Self-Immolative Prodrug Nanomicelle-Hydrogel Modulate Key Intratumoral and Metastatic Genomic Signaling Pathways in Pancreatic Cancer
    Article Snippet: nomedicine has demonstrated numerically higher efficacy and safety compared to standard systemic free drug CT by overcoming some of these challenges, namely: (i) avoiding side and offtarget effects by active biomarker targeting or EPR at the site of interest; (ii) enhancing intracellular uptake in cancer and metastatic cells; (iii) improving controlled payload pharmacokinetics and pharmacodynamics;

    Control:

    Article Title: In Vivo Multimodal Self-Immolative Prodrug Nanomicelle-Hydrogel Modulate Key Intratumoral and Metastatic Genomic Signaling Pathways in Pancreatic Cancer
    Article Snippet: nomedicine has demonstrated numerically higher efficacy and safety compared to standard systemic free drug CT by overcoming some of these challenges, namely: (i) avoiding side and offtarget effects by active biomarker targeting or EPR at the site of interest; (ii) enhancing intracellular uptake in cancer and metastatic cells; (iii) improving controlled payload pharmacokinetics and pharmacodynamics;



    Similar Products

    multiplex microarray detection platform  (Infiniti Medical LLC)
    90
    Infiniti Medical LLC multiplex microarray detection platform
    Multiplex Microarray Detection Platform, supplied by Infiniti Medical LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multiplex+microarray+detection+platform/multiplex+microarray+detection+platform/10__1038_slash_labinvest__2010__33-382-2-6
    Average 90 stars, based on 1 article reviews
    multiplex microarray detection platform - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results